Analysis

Pharmather Holdings Ltd (PHRM) Stock Analysis

Pharmather Holdings Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to PHRM.

websitePHRM/analysis/PHRM

Pharmather Holdings Ltd

Pharmather Holdings Ltd investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to PHRM.

Stock profile

Ticker

PHRM

Asset type

Stock

Market cap

$3.5M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

CAD

Ticker listings

Pharmather Holdings Ltd may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • PHRM primary listing
  • PHRRF
  • NCC0

Latest Pharmather Holdings Ltd news

PharmaTher Evolves Platform Strategy with MEDBOTX(TM) Robotic 3D Printing for Personalized Medicines

PharmaTher Evolves Platform Strategy with MEDBOTX(TM) Robotic 3D Printing for Personalized

PharmaTher's Sairiyo Therapeutics to Explore PD-001, Its Patented Reformulated Cepharanthine, for Hantavirus

Independent research identified cepharanthine as a potential Hantavirus entry inhibitor, supporting further evaluation of Sairiyo's patented, orally bioavailable PD-001 cepharan...

PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness

Company believes supportive U.S. policy momentum may strengthen the strategic value of its ketamine patch, KetaVault™ platform, retained ketamine programs, and prior FDA-approve...

PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides

U.S. regulatory momentum in psychedelics and peptides could open new commercial opportunities for PharmaTher's PatchPrint™ automated manufacturing platform and PharmaPatch™ prod...

PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptid...

PharmaTher Supports Proposed U.S. Peptide Reclassification, Reinforcing the Strategic Value of Its Microneedle Patch Platforms for Peptide

Research sections

Valuation

Review valuation context for Pharmather Holdings Ltd.

Future growth

Review future growth context for Pharmather Holdings Ltd.

Past performance

Review past performance context for Pharmather Holdings Ltd.

Financial health

Review financial health context for Pharmather Holdings Ltd.

Dividend

Review dividend context for Pharmather Holdings Ltd.

Management

Review management context for Pharmather Holdings Ltd.

Ownership

Review ownership context for Pharmather Holdings Ltd.

Other information

Review other information context for Pharmather Holdings Ltd.

Community

Review community context for Pharmather Holdings Ltd.